170 related articles for article (PubMed ID: 33424523)
21. Leveraging immunoinformatics for developing a multi-epitope subunit vaccine against
Tamanna T; Rahman MS
J Biomol Struct Dyn; 2023 Dec; ():1-14. PubMed ID: 38116749
[TBL] [Abstract][Full Text] [Related]
22. Immuno-informatics based approaches to design a novel multi epitope-based vaccine for immune response reinforcement against Leptospirosis.
Validi M; Karkhah A; Prajapati VK; Nouri HR
Mol Immunol; 2018 Dec; 104():128-138. PubMed ID: 30448609
[TBL] [Abstract][Full Text] [Related]
23. Designing an efficient multi-epitope vaccine against Campylobacter jejuni using immunoinformatics and reverse vaccinology approach.
Gupta N; Kumar A
Microb Pathog; 2020 Oct; 147():104398. PubMed ID: 32771659
[TBL] [Abstract][Full Text] [Related]
24. In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori.
Haghighi MA; Mobarez AM; Salmanian AH; Moazeni M; Zali MR; Sadeghi M; Amani J
Indian J Hum Genet; 2013 Jan; 19(1):43-53. PubMed ID: 23901192
[TBL] [Abstract][Full Text] [Related]
25. Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches.
Tahir Ul Qamar M; Ahmad S; Fatima I; Ahmad F; Shahid F; Naz A; Abbasi SW; Khan A; Mirza MU; Ashfaq UA; Chen LL
Comput Biol Med; 2021 May; 132():104389. PubMed ID: 33866250
[TBL] [Abstract][Full Text] [Related]
26. Immunoinformatics-Based Designing of a Multi-Epitope Chimeric Vaccine From Multi-Domain Outer Surface Antigens of
Kumar P; Lata S; Shankar UN; Akif M
Front Immunol; 2021; 12():735373. PubMed ID: 34917072
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
[TBL] [Abstract][Full Text] [Related]
28. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.
Xie W; Zhao W; Zou Z; Kong L; Yang L
Helicobacter; 2021 Jun; 26(3):e12807. PubMed ID: 33847026
[TBL] [Abstract][Full Text] [Related]
29. Protection Against
Pan X; Ke H; Niu X; Li S; Lv J; Pan L
Front Immunol; 2018; 9():1003. PubMed ID: 29867978
[TBL] [Abstract][Full Text] [Related]
30. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
[TBL] [Abstract][Full Text] [Related]
31. An immunoinformatics-based designed multi-epitope candidate vaccine (mpme-VAC/STV-1) against Mycoplasma pneumoniae.
Vilela Rodrigues TC; Jaiswal AK; Lemes MR; da Silva MV; Sales-Campos H; Alcântara LCJ; Tosta SFO; Kato RB; Alzahrani KJ; Barh D; Azevedo VAC; Tiwari S; Soares SC
Comput Biol Med; 2022 Mar; 142():105194. PubMed ID: 35007945
[TBL] [Abstract][Full Text] [Related]
32. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine.
Negahdaripour M; Nezafat N; Eslami M; Ghoshoon MB; Shoolian E; Najafipour S; Morowvat MH; Dehshahri A; Erfani N; Ghasemi Y
Infect Genet Evol; 2018 Mar; 58():96-109. PubMed ID: 29253673
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Protection Against
Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
Front Immunol; 2019; 10():1185. PubMed ID: 31191547
[TBL] [Abstract][Full Text] [Related]
34. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
[TBL] [Abstract][Full Text] [Related]
35. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an
Enayatkhani M; Hasaniazad M; Faezi S; Gouklani H; Davoodian P; Ahmadi N; Einakian MA; Karmostaji A; Ahmadi K
J Biomol Struct Dyn; 2021 May; 39(8):2857-2872. PubMed ID: 32295479
[TBL] [Abstract][Full Text] [Related]
36. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
37. Identification of two novel immunodominant UreB CD4(+) T cell epitopes in Helicobacter pylori infected subjects.
Yang WC; Chen L; Li HB; Li B; Hu J; Zhang JY; Yang SM; Zou QM; Guo H; Wu C
Vaccine; 2013 Feb; 31(8):1204-9. PubMed ID: 23306364
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism.
Lv X; Yang J; Song H; Li T; Guo L; Xing Y; Xi T
Vaccine; 2014 Sep; 32(41):5343-52. PubMed ID: 25093281
[TBL] [Abstract][Full Text] [Related]
39. A Novel Multiepitope Vaccine Against Bladder Cancer Based on CTL and HTL Epitopes for Induction of Strong Immune Using Immunoinformatics Approaches.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Int J Pept Res Ther; 2022; 28(2):71. PubMed ID: 35228842
[TBL] [Abstract][Full Text] [Related]
40. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine.
Dorosti H; Eslami M; Negahdaripour M; Ghoshoon MB; Gholami A; Heidari R; Dehshahri A; Erfani N; Nezafat N; Ghasemi Y
J Biomol Struct Dyn; 2019 Aug; 37(13):3524-3535. PubMed ID: 30634893
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
